A significant milestone – 10 PetaFLOPs
Folding@home has historically been an extremely powerful computing resource. And in 2013, we exceeded the 10 PetaFLOPs barrier.
Read moreFolding@home has historically been an extremely powerful computing resource. And in 2013, we exceeded the 10 PetaFLOPs barrier.
Read moreFAH researcher Dr. Diwakar Shukla has continued work on HD. He has new results on the behavior of the HTT protein and will be presenting his results at the Annual…
Read moreWe are continuing our work with AD in terms of repurposing an existing drug against the leads we have found from Folding@home. The benefit of this approach is that this…
Read moreFAH researchers Dr. Diwakar Shukla and Dr. Morgan Lawrenz have been using Folding@home to understand the fundamental behavior of kinases, key molecular targets in cancer. A paper on these results…
Read moreWe’re very excited to report on our progress towards our goal to develop new small molecule drug candidates for AD. In a paper just published in the Journal of Medicinal…
Read moreWe assisted Chris Garcia’s lab with their work with Interleukin 2 (IL-2), a protein which assists the immune system in fighting pathogens and cancer tumors. While injecting a patient with…
Read moreWe are simulating many forms of Pin1 WW domain, a protein implicated in some cancers and Alzheimer’s disease. Understanding the role of mutations on misfolding can have important biomedical consequences.
Read moreWe’re studying the folding of ubiquitin, a small regulatory protein found in almost all cells in human body. It is part of a large regulatory system that labels other unneeded…
Read moreAt FAHcon 2012, Dr. Xuhui Huang presented our recent results of the molecular mechanisms of gene transcription. Transcription is the first step in reading genomic DNA, and regulation of this…
Read moreDr. Peter Kasson has been applying his work on viruses to cancer, as many cancers are virus-associated.
Read more